ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

New Mexico Program Covers Entire State

January 21, 1977

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977

NCI Contract Awards.

February 18, 2000

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975

NCI Taps Harlow To Head Office of Science Policy

July 26, 1996

In Brief: Hisserich Named USC Assistant VP, Replaced By Rideout At Cancer Center; DeVita Assures Groups

June 27, 1986